#99785
#99786
Re: Farmas USA
#99787
Re: Farmas USA
AcelRx Pharmaceuticals Inc
(NASDAQ:ACRX 3.17 +0.17 (5.83%)
FDA) has accepted the company's New Drug Application (NDA) under section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual tablet, 30 mcg) for the treatment of patients with moderate-to-severe acute pain in a medically supervised setting.
http://finance.yahoo.com/news/acelrx-pharmaceuticals-drug-application-dsuvia-120000464.html
#99788
Re: Farmas USA
#99789
Re: Farmas USA
#99790
Re: Farmas USA
#99791
Re: Farmas USA
#99792
Re: Farmas USA
Ostras, pedazo espiga el IBB/XBI ...
A por los 309?

TEVA consolidando???
